| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England Journal of Medicine 383 (6), 517-525, 2020 | 1561 | 2020 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1026 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 818 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 640 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 603 | 2021 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 240 | 2021 |
| Review: Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open Forum Infectious Diseases 7 (4), ofaa130, 2020 | 236 | 2020 |
| Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... JAMA 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial R Rajasingham, AS Bangdiwala, MR Nicol, CP Skipper, KA Pastick, ... Clinical Infectious Diseases 72 (11), e835-e843, 2021 | 166 | 2021 |
| Decontamination of N95 masks for re-use employing 7 widely available sterilization methods A Kumar, SB Kasloff, A Leung, T Cutts, JE Strong, K Hills, FX Gu, P Chen, ... PloS one 15 (12), e0243965, 2020 | 148* | 2020 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47 (8), 867-886, 2021 | 87 | 2021 |
| Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... JAMA 327 (13), 1247-1259, 2022 | 86 | 2022 |
| Long-Term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... JAMA 329 (1), 39-51, 2023 | 82 | 2023 |
| Adult cardiac surgery and the COVID-19 pandemic: aggressive infection mitigation strategies are necessary in the operating room and surgical recovery DT Engelman, S Lother, I George, DJ Funk, G Ailawadi, P Atluri, MC Grant, ... The Annals of thoracic surgery 110 (2), 707-711, 2020 | 69 | 2020 |
| Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19 SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ... Open Forum Infectious Diseases 7 (11), ofaa500, 2020 | 58 | 2020 |
| Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada SA Lother, GA Harding, G Musto, S Navaratnam, MW Pitz Hormones and Cancer 4 (5), 270-276, 2013 | 43 | 2013 |
| Ramping up delivery of cardiac surgery during the COVID-19 pandemic: a guidance statement from The Society of Thoracic Surgeons COVID-19 Task Force DT Engelman, S Lother, I George, G Ailawadi, P Atluri, MC Grant, JW Haft, ... The Annals of thoracic surgery 110 (2), 712-717, 2020 | 37 | 2020 |
| Ramping up the delivery of cardiac surgery during the COVID-19 pandemic: a guidance statement from the Canadian Society of Cardiac Surgeons A Hassan, RC Arora, SA Lother, C Adams, D Bouchard, R Cook, ... Canadian Journal of Cardiology 36 (7), 1139-1143, 2020 | 35 | 2020 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... JAMA 329 (13), 1066-1077, 2023 | 34 | 2023 |
| Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... JAMA 329 (14), 1183-1196, 2023 | 30 | 2023 |
